18-01-2012

Medicago Inc. and Cellectis plant sciences, a subsidiary of Cellectis SA announced the signing of a research agreement under which Medicago and Cellectis will collaborate to improve therapeutic proteins expressed from tobacco leaves. "We look forward to working with Cellectis plant sciences ...

more

21-01-2011

Cellectis announced that scientists from Cellectis therapeutics, the French National Center For Medical Research (CNRS) and Institut de la Vision (Paris) have used its proprietary meganucleases to successfully prevent infection of cultured cells by a Herpes Simplex virus (HSV-1). The ...

more

25-10-2010

Cellectis and the Center for iPS Cells Research and Application (CiRA) of Kyoto University, Kyoto, Japan, have announced that they have started a scientific collaboration to combine Cellectis’ genome engineering technologies with CiRA’s induced pluripotent stem cell (iPS) technology to ...

more

13-09-2010

Cellectis has announced that it has acquired all the assets of Cyto Pulse Sciences Inc., a US-based company specializing in the development, manufacture and commercialization of electroporation technology and equipment. The transaction value of $2.2 million was paid in cash and closed on ...

more

21-06-2010

Cellectis bioresearch, subsidiary of Cellectis, announced the first edition of The Genome Customization Award, for academic research teams across the world who are undertaking targeted modification of the genome of a cell line or that of a model organism using one or more meganucleases ...

more

09-06-2010

Cellectis bioresearch, subsidiary of Cellectis, and Lonza announced that the companies have entered into an agreement for the development and commercialization of a bioengineered cell line. Cellectis bioresearch will use its meganucleases to deactivate (knock-out) the glutamine synthetase ...

more

28-04-2010

VIB and Cellectis, announced that they are going to collaborate on research into new approaches to cure haemophilia. Thierry Vandendriessche and Marinee Chuah from the VIB Vesalius Research Center at Katholieke Universiteit Leuven are going to use meganucleases – tailor made enzymes ...

more

05-03-2010

Cellectis has announced that BASF Plant Science has just broadened its license to use Cellectis’ meganuclease technology. This agreement extends the license signed by Cellectis and BASF Plant Sciences in January 2006. Under a non-exclusive license, BASF Plant Science will use meganucleases ...

more

22-02-2010

Cellectis and Genoway indicate that the sublicense agreement dated September 7, 2001, relating to the patents and patent applications belonging to the pool WO90/11354 has been terminated as of December 30, 2008. Cellectis and Genoway have agreed on the consequences of such termination of the ...

more

29-01-2010

Cellectis S.A. has won a National Innovation Award from the French National Institute for Industrial Property (INPI). Cellectis IP Manager Michèle Paquier received the award from Thierry Morin, President of the INPI Board, during a ceremony at the Pavillon Gabriel venue in Paris. The ...

more